Metraipolis › archive › dc_744c8708b7af

Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:41058614

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41058614
DOI
10.3389/fmed.2025.1574395
License (as archived)
solo-consultazione
Archived
2026-11-09T19:40:39.853Z
SHA-256 of the archived text
8536c8abd04285605b0838a7ec6c5c303da4001ce334e541d1a5becec56fe1b2
Stable URL of this page
https://metraipolis.com/documento/dc_744c8708b7af

How to cite

Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:41058614 — Europe PMC (en), https://europepmc.org/article/MED/41058614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_744c8708b7af (Metraipolis archive dc_744c8708b7af, sha256 8536c8abd04285605b0838a7ec6c5c303da4001ce334e541d1a5becec56fe1b2)
BibTeX
@misc{dc744c8708b7af,
  title = {Cyclobenzaprine-related adverse events: a comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:41058614},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41058614},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_744c8708b7af; sha256 8536c8abd04285605b0838a7ec6c5c303da4001ce334e541d1a5becec56fe1b2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41058614. Agents can read the archived copy with the MCP tool read_document.